,, 2. : ;,, :(1), (delayed ;(2) ischemic neurological deficit,dind) ;(3) 2. :SAH ;(4) 5-10 10 HT -1-1 ;(5), 10 SAH ;(6) - - 27%~50%, ( cerebral vasospasm ) Glasgow (Glasgow Coma Scale,GCS), [1],, (aneurysmal subarachnoid hemorrhage, SAH),aSAH 22%~49%, [7-10] 2007 10 2008 3 1. : Willis,,,, 1. :1927 Moniz,1937 Dandy,1951 Ecker, 85%,,,,, SAH 17%~60% [2-6],,, 20%~80% 10%~50% SAH(tSAH)
3. :(1), 4 Hess (WFNS) 1 asah;2tsah;3 1 ; 1 4 (2) [13]a 3 :1, Hunt and Hess WFNS [14] Glasgow 15, I ;2 Glasgow 13 14 II, ;3 Glasgow 13 14 III (3) Glasgow 7 12, IV 3 : 50% ; Glasgow 25% ~50%; <25% (4) V 3 6 :a ( ) 1 ; 24, 0 I a, 3. :(1) (DSA): (orthogonal polarization spectral imaging),, 2003,aSAH SAH ( ) 50%, [15] 75% [11], (2) SAH 3~5 TCD 7~10 2~3 [12] 1. :(1) : TCD, (2) : TCD, SAH 3~5, d,, ( ),CT (3)CT:CT 12h SAH, CT - - 2. : asah, Hunt and (TCD) :TCD > 200cm/s ( ) >120cm/s SAH
SAH CT asah tsah CT, 7d CT (5) 50% CT (HCT< 30%),CT SAH 24h CT ( ) Fisher [16] 2 (4)CTA MRA: CT CTA CT ( CTA), A1,, 2 Fisher CT 1. : asah asah, % 0 3 1 14 2 38 3 SAH!"# $ 57 4 % & () 57 (6) 2. : SAH, SAH, SAH,,, 3. : (1) :,, DSA TCD CTA, 2007 Cochrane, asah, [17], SAH 3~5 2~3, (AHA) [18] [19] [20] asah 4 (1) TCD, :, : 1 (2) TCD :asah :,, J Neurosurg,aSAH (3) [21] TCD, 2006 (4) Neurosurg Rev
asah [22],2007 Neurosurgery 1d [23] 2 4. : : asah 2~3, : 14~21d Youmans Neurological Surgery 5,,60% ~ 80% 21d [24] 14d 3 :, 70kg : 0.5mg/h,2h 1mg/ h; 70kg : 1mg/h,2h 2mg/h 24~ 3H 48mg 1.5h 60mg, 4 h 1 4 :2007 Cochrane,, [17] asah 140 ~ 200 mmhg (1 mm Hg=0.133 kpa) [25] 5 [26] : (1:19, (2) / ), 8 ~10, (2) : mmhg, 100~130 cm H 2 O (1 cm H 2 O=0.098 kpa) (3) 10mg/Kg, 30mg 30%~35% kg -1 d -1 3H, (3) : ;, :0.3%,, 100 ml 0.1 ml/s : ;CT ; (4) ; : Rho, SAH (275 SAH ), SAH 2,, 2~ 3 30 mg 30 min, 5. : :(1),,,
intravascular coiling on cerebral vasospasm and patient outcome after aneurismal subarachnoid hemorrhage. Neurosurgery, 2004,55: 779-786. [7] Origitano TC, al-mefty O, Leonetti JP, et al. Vascular considerations and complications in cranial base surgery. Neurosurgery, 1994,35:351-362. [8],1997, 35:522-526. [9] TCD,2004,3:442-444. [10] el Hendawy M, Wroński J, Juniewicz H, et al. Cerebral vasospasm detection by TCD after supratentorial brain tumours surgery. Neurol Neurochir Pol, 2000,34Suppl 6:114-123. [11] Eberhard UHL, Jens L, Hans-Jakob S, et al. Intraoperative detection of early microvasospasm in patients with subarachnoid hemorrhage by using orthogonal polarization spectral imaging. Neurosurgery, 2003, 52: 1307-1317. [12] Seiler RW, Grolimund P, Zurbruegg HR, et al. Evaluation of the calcium- nimodipine for the prevention of vasospasm after aneurysmal sub- antagonist arachnoid haemorrhage. A prospective transcranial Doppler ultrasound study. Acta Neurochirurgica, 1987,85:7-16. [13] Kosty Toni. Cerebral vasospasm after subarachnoid hemorrhage. An update. Crit Care Nurs Q, 2005,28: 122-134. [14] Report of World Federation of Neurological Surgeons Committee on a univer- subarachnoid hemorrhage grading scale. J Neurosurg,1988,68:985-986. sal [15] Janjua N, Mayer SA. Cerebral vasospasm after subarachnoid hemorrhage. Curr Opin Crit Care, 2003, 9:113-119. [16] Zervas NT, Ogilvy CS. Cerebral vasospasm: current clinical management and results. Clin Neurosurg, 1999,45:167-76. [17] Dorhout Mees SM, Rinkel GJE, Feigin VL, et al. Calcium antagonists for a neurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev, 2007,18: CD000277. [18] Mayberg MR, Batjer HH, Dacey R, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Circulation, 1994,90:2592-2605. [19] Findlay JM. Current management of aneurysmal subarachnoid hemorrhage guidelines from the Canadian Neurosurgical Society. Can J Neurol Sci. 1997, [1] Oertel M, Boscardin WJ, Obrist WD, et al. Posttraumatic vasospasm: the epidemiology, 24:161-170. severity, and time course of an underestimated phenomenon: a [20] Gensini GF, Zaninelli A, Bignamini AA, et al. Italian Guidelines for stroke prospective study performed in 299 patients. J Neurosurg, 2005, 103:812- Prevention and Management. 2005, March. 824. [21] Barker FG, Ogilvy CS. Efficacy of prophylactic nimodipine for delayed ischemic [2] Hohlrieder M, Spiegel M, Hinterhoelzl J, et al. Cerebral vasospasm and ischaemic deficit after subarachnoid hemorrhage: a meta analysis. J Neurosurg. infarction in clipped and coiled intracranial aneurysm patients. Eur 1996,84:405-414. J Neurol, 2002,9:389-399. [22] Macdonald RL. Management of cerebral vasospasm. Neurosurg Rev, 2006,29: [3] Rabinstein AA, Pichelmann MA, Friedman JA, et al. Symptomatic vasospasm 179-193. and outcomes following aneurysmal subarachnoid hemorrhage: a comparison [23] Scheller C, Richter H-P, Engelhardt M, et al. The influence of prophylactic between surgical repair and endovascular coil occlusion. J Neurosurg, 2003, vasoactive treatment on cochlear and facial nerve functions after vestibular 98:319-325. schwannoma surgery: a prospective and open-label randomized pilot study. [4] Taha MM, Nakahara I, Higashi T, et al. Endovascular embolization vs surgical clipping in treatment of cerebral aneurysms: morbidity and mortality with Neurosurgery, 2007,61:92-98. [24] H. Richard Winn. Youmans neurological surgery. 5th ed, 2004. short-term outcome. Surg Neurol, 2006,66:277-284. [25] Harders A, Kakarieka A, Braakman R. Traumatic subarachnoid hemorrhage [5] Molyneux AJ, Kerr RS, Yu LM, et al. International subarachnoid aneurysm and its treatment with nimodipine. German tsah Study Group. J Neurosurg, trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 1996,85:82-89. patients with ruptured intracranial aneurysms: a randomized comparison of [26] Auer LM, Nimodipine and early aneurysm operation in good condition SAH effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm patients. Acta Neurochir. 1986,82:7-13. occlusion. Lancet, 2005,366:809-817. [6] Hoh BL, Topcuoglu MA, Singhal AB, et al. Effect of clipping, craniotomy, or....